APA (7th ed.) Citation

L, Y., J, G., SL, K., N, G., KM, E., K, S., . . . I, H. (2025). Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis. Pharmacoepidemiology and drug safety, 34(2), e70098. https://doi.org/10.1002/pds.70098

Chicago Style (17th ed.) Citation

L, Yang, Guo J, Kane-Gill SL, Gabriel N, Empey KM, Suh K, Kirisci L, and Hernandez I. "Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis." Pharmacoepidemiology and Drug Safety 34, no. 2 (2025): e70098. https://doi.org/10.1002/pds.70098.

MLA (9th ed.) Citation

L, Yang, et al. "Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis." Pharmacoepidemiology and Drug Safety, vol. 34, no. 2, 2025, p. e70098, https://doi.org/10.1002/pds.70098.